Ameren (NYSE: AEE) revenue
Ameren reported revenue of $8,799m for fiscal 2025, 15.4% more than in fiscal 2024 ($7,623m). Since fiscal 2016 its revenue has grown by 44.8%, an average growth of 4.2% a year.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $8,799m | +15.4% | $2,026m | 23.0% |
| 2024 | $7,623m | +1.6% | $1,516m | 19.9% |
| 2023 | $7,500m | −5.7% | $1,558m | 20.8% |
| 2022 | $7,957m | +24.4% | $1,515m | 19.0% |
| 2021 | $6,394m | +10.4% | $1,333m | 20.8% |
| 2020 | $5,794m | −2.0% | $1,300m | 22.4% |
| 2019 | $5,910m | −6.1% | $1,267m | 21.4% |
| 2018 | $6,291m | +1.9% | $1,357m | 21.6% |
| 2017 | $6,174m | +1.6% | $1,410m | 22.8% |
| 2016 | $6,076m | — | $1,322m | 21.8% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Questions about the revenue of Ameren
- How much revenue did Ameren make in fiscal 2025?
- Ameren reported revenue of $8,799m for fiscal 2025, compared with $7,623m in fiscal 2024.
- How much has the revenue of Ameren grown?
- Between fiscal 2016 and fiscal 2025 it went from $6,076m to $8,799m: 44.8% more, an average growth of 4.2% a year.
- What was the best year for revenue at Ameren?
- Of its last 10 fiscal years, fiscal 2025, with $8,799m.
- Where do the figures for Ameren come from?
- From the annual report (Form 10-K) that Ameren files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Ameren files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Ameren: the Ameren page · annual accounts · net income · dividends paid · insider transactions.
Dividend per share of Ameren by fiscal year, with the filing behind every figure: Ameren dividend history.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.